Phase I/II Study of Decitabine (DAC) Followed by Clofarabine, Idarubicin, and Cytarabine (CIA) in Acute Leukemia
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 25 May 2017
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine; Decitabine; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 19 May 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Dec 2016 Interim results (n=54) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 26 Oct 2016 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.